Collegium Pharmaceutical (COLL) Treasury Shares (2014 - 2026)

Collegium Pharmaceutical has reported Treasury Shares for 9 years, with the latest figure at $222.5 million in Q2 2026.

• On a quarterly basis, Treasury Shares rose 2.3% year-over-year to $222.5 million in Q2 2026; TTM through Jun 2026 was $222.5 million, a 2.3% increase from a year earlier, with the FY2025 full-year figure at $222.5 million, up 12.66% from the prior year.
• Treasury Shares was $222.5 million for Q2 2026 at Collegium Pharmaceutical, roughly flat from $222.5 million in the prior quarter.
• The five-year high for Treasury Shares was $9.0 million in Q3 2025, with the low at $2.5 million in Q1 2022.
• Average Treasury Shares over 5 years is $6.2 million, with a median of $6.8 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Treasury Shares jumped 210.54% in 2022, then gained 2.3% in 2026.
• Over 5 years, Treasury Shares stood at $61.9 million in 2022, then jumped by 121.85% to $137.4 million in 2023, then soared by 43.76% to $197.5 million in 2024, then gained by 12.66% to $222.5 million in 2025, then changed by 0.0% to $222.5 million in 2026.
• The last three Treasury Shares figures came in at $222.5 million (Q2 2026), $222.5 million (Q1 2026), and $222.5 million (Q4 2025), per Business Quant data.